Dydrogesterone

Founded in 2004 and based in Minhang District, Shanghai, Shanghai Utopharm Co.,Ltd. (utopharm.com) manufactures and exports active pharmaceutical ingredients and finished dosage forms, with organic synthesis capability spanning small-scale test reactions through larger production runs. Its catalog includes apremilast, rasagiline mesylate, licofelone, cisatracurium besylate, vitamin D2, ulipristal acetate, dydrogesterone, ivabradine hydrochloride, prasugrel and tolvaptan, alongside steroid and benzazepine synthetic intermediates. Offering CRO and CMO contract services, the company is categorized across prophylactic biological products, vitamins, intermediates/fine chemicals, chiral intermediates, hormones and cardiovascular drugs, and it positions itself on brand strength, experienced R&D personnel, production capacity, a rich product line, and willingness to accommodate buyer specifications and small orders, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.